About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
410 genotypes with 465 annotations displayed of selected term and subterms
Searched Term: abnormal seizure response to inducing agent
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Adamts4tm1Dgen/Adamts4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Adgrv1frings/Adgrv1frings
(RB/1) 		audiogenic seizures J:25341
Adgrv1frings/Adgrv1frings
(BUB/BnJ) 		audiogenic seizures J:97534
Adgrv1tm1Msat/Adgrv1tm1Msat
(involves: 129P2/OlaHsd * C57BL/6J) 		audiogenic seizures J:95518
Adgrv1tm1Msat/Adgrv1tm1Msat
(B6.129P2-Adgrv1tm1Msat) 		audiogenic seizures J:95518
Adgrv1tm1Pwh/Adgrv1tm1Pwh
(involves: 129S1/Sv * C57BL/6J) 		audiogenic seizures J:90899
Adktm2Bois/Adktm2Bois
Adora1tm1Bbf/Adora1tm1Bbf
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		environmentally induced seizures J:237189
Adktm2Bois/Adktm2Bois
Adora2atm1Jfc/Adora2atm1Jfc
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased susceptibility to induction of seizure by inducing agent J:237189
Adktm2Bois/Adktm2Bois
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		environmentally induced seizures J:237189
increased susceptibility to pharmacologically induced seizures J:237189
Agpat1tm1Garg/Agpat1tm1Garg
(involves: 129S6/SvEvTac * C57BL/6) 		audiogenic seizures J:250301
Aifm1Hq/Y
(B6CBACa Aw-J/A-Aifm1Hq/J) 		abnormal seizure response to pharmacological agent J:98103
Aifm1Hq/Aifm1Hq
(B6CBACa Aw-J/A-Aifm1Hq/J) 		abnormal seizure response to pharmacological agent J:98103
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6 * FVB/N) 		decreased susceptibility to pharmacologically induced seizures J:138972
Akt3Nmf350/Akt3+
(C57BL/6J-Akt3Nmf350) 		abnormal seizure response to electrical stimulation J:169028
increased susceptibility to pharmacologically induced seizures J:169028
maximal tonic hindlimb extension seizures J:169028
Akt3Nmf350/Akt3Nmf350
(C57BL/6J-Akt3Nmf350) 		abnormal seizure response to electrical stimulation J:169028
increased susceptibility to pharmacologically induced seizures J:169028
maximal tonic hindlimb extension seizures J:169028
Akt3tm1Mbb/Akt3tm1Mbb
(involves: C57BL/6J) 		abnormal seizure response to electrical stimulation J:169028
maximal tonic hindlimb extension seizures J:169028
Alg13em1Bayu/Y
(involves: C57BL/6J) 		environmentally induced seizures J:275180
increased susceptibility to pharmacologically induced seizures J:275180
Amphtm1Pdc/Amphtm1Pdc
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:75306
Ano3tm1.1Lyj/Ano3tm1.1Lyj
Ptgdstm1.1(cre)Gvn/Ptgds+
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		environmentally induced seizures J:310618
Ano3tm1.1Lyj/Ano3tm1.1Lyj
Tg(Nes-cre)1Kln/0
(involves: 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:310618
Ap3m2tm1Ohno/Ap3m2tm1Ohno
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal kindling response J:93312
increased susceptibility to pharmacologically induced seizures J:93312
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc) 		abnormal kindling response J:118390
Arhgap32tm1Taki/Arhgap32tm1Taki
(B6N.Cg-Arhgap32tm1Taki) 		increased susceptibility to pharmacologically induced seizures J:236753
Arxtm3Kki/Y
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:152416
Asnsd1Gt(OST460318)Lex/Asnsd1Gt(OST460318)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		environmentally induced seizures J:320329
Asp1/Asp1
(DBA/2J) 		audiogenic seizures J:6355
Asp2/Asp2
(DBA/2J) 		audiogenic seizures J:11261, J:5094
Asp3DBA/2J/Asp3DBA/2J
(DBA/2J) 		audiogenic seizures J:11261
Atp1a3Myk/Atp1a3+
(B6NCr.129S1-Atp1a3Myk) 		abnormal seizure response to inducing agent J:180250
environmentally induced seizures J:151948
Atp1a3Myk/Atp1a3+
(involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr) 		environmentally induced seizures J:151948
Atp1a3tm1.1Tmklh/Atp1a3+
(B6JRj.129S1-Atp1a3tm1.1Tmklh) 		increased susceptibility to pharmacologically induced seizures J:254463
Atp1a3tm1Mika/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal seizure response to inducing agent J:264408
increased kindling response J:264408
Atp1a3tm1Ute/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased kindling response J:262419
increased susceptibility to pharmacologically induced seizures J:262419
Atp6v1b2em1Pcamp/Atp6v1b2+
(C57BL/6N-Atp6v1b2em1Pcamp) 		increased susceptibility to pharmacologically induced seizures J:342781
Atp6v1b2em1Pcamp/Atp6v1b2em1Pcamp
(C57BL/6N-Atp6v1b2em1Pcamp) 		environmentally induced seizures J:342781
increased susceptibility to pharmacologically induced seizures J:342781
Atp6v1b2tm1Yoyu/Atp6v1b2tm1Yoyu
(involves: C57BL/6) 		environmentally induced seizures J:278514
Avpr1btm1Dgen/Avpr1btm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
B4galnt1tm1Rlp/B4galnt1tm1Rlp
St8sia1tm1Rlp/St8sia1tm1Rlp
(involves: 129S6/SvEvTac) 		audiogenic seizures J:67955
Baiap3tm1Smwk/Baiap3tm1Smwk
(B6N.129P2-Baiap3tm1Smwk) 		increased susceptibility to pharmacologically induced seizures J:221234
Bdnftm3Jae/Bdnftm3Jae
Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR) 		abnormal kindling response J:91467
Bhlhe40tm1.1Rhli/Bhlhe40tm1.1Rhli
(involves: 129S1/Sv * C57BL/6 * CD-1 * SJL) 		increased susceptibility to pharmacologically induced seizures J:131834
Bis1C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
Bis4A/J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
Bsntm1Gund/Bsntm1Gund
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:82241
Cacna1atg/Cacna1atg
(B6.D2-Cacna1atg/J) 		increased susceptibility to pharmacologically induced seizures J:6154
Cacna1atm1.1Sher/Cacna1atm1.1Sher
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		abnormal seizure response to inducing agent J:170451
environmentally induced seizures J:170451
Cacna1gtm1Hssh/Cacna1gtm1Hssh
(involves: 129S4/SvJae * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:70557
Cacna2d2tm1Svi/Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:92396
Car7tm1.1Kkai/Car7tm1.1Kkai
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:200079
Cdk5r1tm1Lht/Cdk5r1tm1Lht
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:38857
Cdkl5tm1.2Cogr/Y
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J) 		abnormal seizure response to inducing agent J:209635
Cdkl5tm1.2Cogr/Cdkl5tm1.2Cogr
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J) 		abnormal seizure response to inducing agent J:209635
Cdyltm1.1Yuw/Cdyltm1.1Yuw
Emx1tm1(cre)Yql/Emx1+
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:251551
Celf4Ff/Celf4+
(involves: C57BL/6J) 		abnormal seizure response to electrical stimulation J:123744
Celf4tm1.1Frk/Celf4tm1.1Frk
Emx1tm1(cre)Krj/?
(involves: 129 * C57BL/6J) 		increased susceptibility to induction of seizure by inducing agent J:19671
Celf4tm1.1Frk/Celf4tm1.1Frk
Tg(Camk2a-cre)1Lfr/0
(involves: 129 * C57BL/6J) 		increased susceptibility to induction of seizure by inducing agent J:194671
Celf4tm1.1Frk/Celf4tm1.1Frk
Tg(Slc32a1-cre)2.1Hzo/0
(involves: 129 * C57BL/6J * FVB) 		decreased susceptibility to induction of seizure by inducing agent J:194671
Chrna4tm1Dra/Chrna4tm1Dra
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:97020
Chrna5tm1Mdb/Chrna5tm1Mdb
(B6.129-Chrna5tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
Chrna5tm1Mdb/Chrna5tm1Mdb
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb Chrna5tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
Chrna7tm1Bay/Chrna7tm1Bay
(B6.Cg-Chrna7tm1Bay) 		abnormal seizure response to pharmacological agent J:74703
Chrnb2tm1.1Cont/Chrnb2+
(B6.129-Chrnb2tm1.1Cont) 		increased susceptibility to induction of seizure by inducing agent J:228269
Chrnb2tm1.1Cont/Chrnb2tm1.1Cont
(B6.129-Chrnb2tm1.1Cont) 		increased susceptibility to induction of seizure by inducing agent J:228269
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb) 		decreased susceptibility to pharmacologically induced seizures J:89266
Cittm1Fdc/Cittm1Fdc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		increased susceptibility to pharmacologically induced seizures J:77297
Ckbtm1Bew/Ckbtm1Bew
(involves: 129P/Ola * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:89399
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:80901
Cln3tm1Blda/Cln3tm1Blda
(B6.129-Cln3tm1Blda) 		increased susceptibility to pharmacologically induced seizures J:125194
Cnr1tm1.1Ltz/Cnr1+
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
Cnr1tm1.1Ltz/Cnr1tm1.1Ltz
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
(involves: 129P2/OlaHsd * C57BL/6NCrl) 		increased susceptibility to pharmacologically induced seizures J:122066
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Neurod6tm1(cre)Kan/Neurod6+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6NCrl) 		increased susceptibility to pharmacologically induced seizures J:122066
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:89842
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Tg(Camk2a-cre)2Gsc/?
(involves: 129P2/OlaHsd * C57BL/6NCrl * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:122066
Cnr1tm2Ltz/Cnr1tm2Ltz
(B6.Cg-Cnr1tm2Ltz) 		increased susceptibility to pharmacologically induced seizures J:199647
Cntn2tm1Fuka/Cntn2tm1Fuka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:67556
Cntn5tm1Kwat/Cntn5tm1Kwat
(involves: 129X1/SvJ * C57BL/6J) 		audiogenic seizures J:89425
Cntnap2tm1Pele/Cntnap2tm1Pele
(B6.129-Cntnap2tm1Pele) 		environmentally induced seizures J:177110
Coq8atm1.1Ics/Coq8atm1.1Ics
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N) 		environmentally induced seizures J:249129
increased susceptibility to pharmacologically induced seizures J:249129
Cosz1DBA/2J/Cosz1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cosz2DBA/2J/Cosz2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cosz3C57BL/6J/Cosz3C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cosz3C57BL/6J/Cosz3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:66464
Cremtm1.1Endo/Cremtm1.1Endo
(C57BL/6-Cremtm1.1Endo) 		abnormal kindling response J:137666
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Emx1tm1(cre)Yql/Emx1+
(B6.129-Emx1tm1(cre)Yql Ctnnb1tm2Kem) 		increased susceptibility to pharmacologically induced seizures J:92923
Cul4btm1Swl/Y
Edil3Tg(Sox2-cre)1Amc/Edil3+
(B6.Cg-Edil3Tg(Sox2-cre)1Amc Cul4btm1Swl) 		increased susceptibility to pharmacologically induced seizures J:187403
Dbptm1Schb/Dbptm1Schb
Hlftm1Schb/Hlftm1Schb
Teftm1Schb/Teftm1Schb
(involves: 129P2/OlaHsd * 129S2/SvPas) 		audiogenic seizures J:90854
Del(5D5Mit73-D5Mit351)5Jcs/+
(involves: 129S4/SvJae * C57BL/6J) 		maximal tonic hindlimb extension seizures J:67077
Del(5D5Mit388-D5Mit351)4Jcs/+
(involves: 129S4/SvJae * C57BL/6J) 		abnormal seizure response to electrical stimulation J:67077
Del(5Letm1-D5Mit81)3Jcs/+
(involves: 129S4/SvJae * C57BL/6J) 		abnormal seizure response to electrical stimulation J:67077
Del(7Chrna7-Fan1)3Arte/+
(involves: C57BL/6J * C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:260165
abnormal seizure response to pharmacological agent J:260165
decreased susceptibility to pharmacologically induced seizures J:260165
Del(XArmcx5-Nxf3)3Jw/+
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		environmentally induced seizures J:210663
Del(XNxf2-Nxf3)1Jw/+
(involves: 129S4/SvJae * C57BL/6 * FVB) 		audiogenic seizures J:210663
environmentally induced seizures J:210663
Depdc5tm1c(EUCOMM)Hmgu/Depdc5tm1c(EUCOMM)Hmgu
Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6N * CBA) 		increased susceptibility to pharmacologically induced seizures J:260943
Dnm1Ftfl/Dnm1+
(C57BL/6J-Dnm1Ftfl) 		abnormal kindling response J:163311
abnormal seizure response to electrical stimulation J:163311
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:65767
Dyrk1aem1Kzy/Dyrk1a+
(C57BL/6J-Dyrk1aem1Kzy) 		environmentally induced seizures J:259596
Ecpasem1Plch/Ecpasem1Plch
(C57BL/6-Ecpasem1Plch) 		increased susceptibility to pharmacologically induced seizures J:282974
Eef1dtm1.2Mkma/Eef1dtm1.2Mkma
(B6J.B6N(Cg)-Eef1dtm1.2Mkma) 		audiogenic seizures J:288930
Efhc1tm1Kzy/Efhc1+
(B6.129P2-Efhc1tm1Kzy) 		increased susceptibility to pharmacologically induced seizures J:145858
Efhc1tm1Kzy/Efhc1tm1Kzy
(B6.129P2-Efhc1tm1Kzy) 		increased susceptibility to pharmacologically induced seizures J:145858
Elfn1tm1.1Jaru/Elfn1tm1.1Jaru
(involves: C57BL/6) 		environmentally induced seizures J:226212
increased susceptibility to pharmacologically induced seizures J:226212
Elfn2tm1(KOMP)Vlcg/Elfn2tm1(KOMP)Vlcg
(C57BL/6NTac-Elfn2tm1(KOMP)Vlcg) 		audiogenic seizures J:286127
increased susceptibility to pharmacologically induced seizures J:286127
Elp1tm1Id/Elp1tm1.1Id
Tg(Hsp70-1-cre)6Arge/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA) 		audiogenic seizures J:188923
environmentally induced seizures J:188923
Elp1tm1Id/Elp1tm1Id
Tg(Hsp70-1-cre)6Arge/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA) 		audiogenic seizures J:188923
environmentally induced seizures J:188923
Eml1heco/Eml1heco
(involves: NOR) 		increased susceptibility to pharmacologically induced seizures J:208031
Emx1tm1.1(cre)Ito/Emx1+
Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:139349
Exq1A/J/?
(involves: A/J * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:54925
Exq1C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal seizure response to pharmacological agent J:54925
Faim2tm1Dgen/Faim2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(B6.129S4-Fcgr2btm1Ttk) 		abnormal seizure response to electrical stimulation J:169028
maximal tonic hindlimb extension seizures J:169028
Fgf7tm1Efu/Fgf7tm1Efu
(B6.129-Fgf7tm1Efu) 		increased susceptibility to pharmacologically induced seizures J:161954
Fgf13tm1Jom/Fgf13+
(C57BL/6-Fgf13tm1Jom) 		abnormal kindling response J:222555
environmentally induced seizures J:222555
Fgf14tm1Dor/Fgf14tm1Dor
(129S6/SvEvTac-Fgf14tm1Dor) 		increased susceptibility to pharmacologically induced seizures J:77806
Fgf14tm1Dor/Fgf14tm1Dor
(B6.129S6-Fgf14tm1Dor) 		increased susceptibility to pharmacologically induced seizures J:77806
Fgf22tm1Dgen/Fgf22tm1Dgen
(B6.Cg-Fgf22tm1Dgen) 		decreased susceptibility to pharmacologically induced seizures J:161954
Fmr1tm1Cgr/Y
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		audiogenic seizures J:127792
Fmr1tm1Cgr/Y
(either: FVB.129P2(B6)-Fmr1tm1Cgr/J or FVB;129P2(B6)-Fmr1tm1Cgr/J) 		audiogenic seizures J:85912
Fmr1tm1Cgr/Y
Grm5tm1Rod/Grm5+
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		audiogenic seizures J:127792
Fmr1tm1Rbd/Y
(B6.129-Fmr1tm1Rbd) 		audiogenic seizures J:155593
Fosbtm1Meg/Fosbtm1Meg
(involves: 129S4/SvJae * 129X1/SvJ) 		abnormal seizure response to electrical stimulation J:110995
Fyntm1Yik/Fyntm1Yik
(involves: C57BL/6 * CBA) 		audiogenic seizures J:23384
Fzd9tm1Sjp/Fzd9tm1Sjp
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:99893
Gabbr1tm1Bet/Gabbr1tm1Bet
(BALB/c-Gabbr1tm1Bet) 		audiogenic seizures J:70558
Gabra1tm1.1Geh/Gabra1+
(B6.129(Cg)-Gabra1tm1.1Geh) 		increased susceptibility to pharmacologically induced seizures J:227437
Gabra1tm1.1Mjga/Gabra1+
(B6J.Cg-Gabra1tm1.1Mjga) 		increased susceptibility to pharmacologically induced seizures J:227437
Gabra1tm1.1Uru/Gabra1tm1.1Uru
(either: 129X1.129P2-Gabra1tm1.1Uru or B6.129P2-Gabra1tm1.1Uru) 		increased susceptibility to pharmacologically induced seizures J:75895
Gabrb3tm2.1Uru/Gabrb3tm2.1Uru
(B6J.129S6(Cg)-Gabrb3tm2.1Uru) 		increased susceptibility to pharmacologically induced seizures J:228332
Gabrdtm1.1Jmag/Gabrd+
Gad2tm2(cre)Zjh/Gad2+
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased susceptibility to pharmacologically induced seizures J:203336
Gabrg2tm1.2Rmac/Gabrg2+
(involves: C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:306976
Gabrg2tm1Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:127120
Gabrg2tm1Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		increased susceptibility to pharmacologically induced seizures J:194736
Gabrg2tm2Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to pharmacologically induced seizures J:194196
Gabrg2tm2Spet/Gabrg2+
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:194736
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn) 		increased susceptibility to pharmacologically induced seizures J:77625
Gdi1tm1Ytk/Gdi1tm1Ytk
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * C57BL/6 * DBA/2)) 		increased susceptibility to pharmacologically induced seizures J:65258
Gfaptm2Mes/Gfap+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:114689
Gfra2tm1Msa/Gfra2tm1Msa
(either: (involves: 129S1/Sv * 129S2/SvHsd * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NHsd)) 		decreased kindling response J:53284
Glra1tm1.1Geh/Glra1tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:177105
Glra1tm2.1Geh/Glra1tm2.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:177106
Glra3tm1Dgen/Glra3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Gnao1em1Rneu/Gnao1+
(involves: C57BL/6J * C57BL/6NCrl) 		increased kindling response J:271137
Gnao1tm2.1Rneu/Gnao1+
(B6.129S-Gnao1tm2.1Rneu) 		abnormal kindling response J:216850
Gnb1em1Dgold/Gnb1+
(C57BL/6NJ-Gnb1em1Dgold) 		minimal clonic seizures J:346983
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: FVB/N) 		audiogenic seizures J:92791
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: C57BL/6J * FVB/N) 		audiogenic seizures J:92791
Gng3tm1.1Rbs/Gng3tm1.1Rbs
Gng7tm1Lex/Gng7tm1Lex
(B6.Cg-Gng7tm1Lex Gng3tm1.1Rbs) 		environmentally induced seizures J:182775
Gria3tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
Gria4tm1Dgen/Gria4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal seizure response to pharmacological agent J:101679
Grik2tm1Bvis/Grik2tm1Bvis
(129S/Sv-Grik2tm1Bvis) 		increased susceptibility to pharmacologically induced seizures J:107698
Grik2tm1Sfh/Grik2tm1Sfh
(involves: 129S1/Sv * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:46932
Grik4tm1(cre)Mim/Grik4+
Grin1tm1Mim/Grin1tm1Mim
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:144994
Grik5tm1Dgen/Grik5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Grin1tm1Blt/Grin1tm1Blt
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:62289
Grin2atm1Rsp/Grin2atm1Rsp
(involves: 129S1/Sv * 129X1/SvJ) 		decreased kindling response J:45446
Grm5tm1Dgen/Grm5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:82809
increased susceptibility to pharmacologically induced seizures J:82809
Grm7tm1Betz/Grm7tm1Betz
(B6.129P2-Grm7tm1Betz) 		increased susceptibility to pharmacologically induced seizures J:138831
Grm7tm1Dgen/Grm7tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Gsg1ltm1.2Tern/Gsg1ltm1.2Tern
(C57BL/6J-Gsg1ltm1.2Tern) 		increased susceptibility to pharmacologically induced seizures J:301313
Gt(ROSA)26Sortm1(Crh)Jde/Gt(ROSA)26Sortm1(Crh)Jde
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		abnormal seizure response to pharmacological agent J:140968
Hcn2ap/Hcn2+
(DW/Pas-Hcn2ap) 		increased susceptibility to pharmacologically induced seizures J:146530
Hcrtr1tm1Dgen/Hcrtr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Hdac4Gt(OST361114)Lex/Hdac4Gt(OST361114)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		environmentally induced seizures J:152466
Hexbtm1Grv/Hexbtm1Grv
(either: (involves: 129P2/Ola * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * C57L/6J)) 		abnormal seizure response to electrical stimulation J:30899
Hnrnph2em1Jpat/Y
(C57BL/6J-Hnrnph2em1Jpat) 		audiogenic seizures J:338313
Hnrnph2em1Jpat/Hnrnph2+
(C57BL/6J-Hnrnph2em1Jpat) 		audiogenic seizures J:338313
Hnrnph2em2Jpat/Y
(C57BL/6J-Hnrnph2em2Jpat) 		audiogenic seizures J:338313
Hnrnph2em2Jpat/Hnrnph2em2Jpat
(C57BL/6J-Hnrnph2em2Jpat) 		audiogenic seizures J:338313
Hnrnpuem1Frk/Hnrnpu+
(Not Specified) 		maximal tonic hindlimb extension seizures J:342579
Hprt1tm1(CAG-Glra3*)Jcme/Y
Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		increased susceptibility to pharmacologically induced seizures J:207981
Hrh2tm1Yfks/Hrh2tm1Yfks
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal seizure response to electrical stimulation J:102252
Htr1atm1Toth/Htr1atm1Toth
(involves: 129P2/OlaHsd * Black Swiss) 		increased susceptibility to pharmacologically induced seizures J:66581
Htr2ctm1Jul/Y
(either: (involves: 129S2/SvPas * C57BL/6J * DBA/2) or (involves: 129S4/SvJae * C57BL/6J * DBA/2)) 		increased susceptibility to pharmacologically induced seizures J:24339
Htr4tm1Comp/Htr4tm1Comp
(129/Sv-Htr4tm1Comp) 		increased susceptibility to pharmacologically induced seizures J:87451
Htr7tm1Wtkn/Htr7tm1Wtkn
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal seizure response to electrical stimulation J:124549
increased susceptibility to pharmacologically induced seizures J:124549
Htttm1Mem/Htttm6Mem
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * Swiss Webster) 		environmentally induced seizures J:260244
Igsf9tm1Kln/Igsf9tm1Kln
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:209586
Impa1tm1Lex/Impa1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:157887
Iqsec2em1Frk/Y
(involves: C3HeB/FeJ * C57BL/6NJ) 		decreased susceptibility to induction of seizure by inducing agent J:284762
decreased susceptibility to pharmacologically induced seizures J:284762
Iqsec2em1Frk/Iqsec2+
(involves: C3HeB/FeJ * C57BL/6NJ) 		decreased susceptibility to induction of seizure by inducing agent J:284762
Juntm2.1Wag/Juntm2.1Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:53481
Kcna1tm1Tem/Kcna1+
(involves: 129S7/SvEvBrd * various) 		increased susceptibility to pharmacologically induced seizures J:47349
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * various) 		increased susceptibility to pharmacologically induced seizures J:47349
Kcna2tm1Tem/Kcna2+
(C3Fe.129S7-Kcna2tm1Tem) 		increased susceptibility to pharmacologically induced seizures J:131735
Kcna2tm1Tem/Kcna2tm1Tem
(C3Fe.129S7-Kcna2tm1Tem) 		increased susceptibility to pharmacologically induced seizures J:131735
Kcnc2tm1Rudy/Kcnc2tm1Rudy
(B6.129S1-Kcnc2tm1Rudy) 		increased susceptibility to pharmacologically induced seizures J:66730
Kcnh3tm1.2Tije/Kcnh3tm1.2Tije
(involves: C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:165296
Kcnip1tm1Zhzh/Kcnip1tm1Zhzh
(involves: C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:227383
Kcnj6tm1Stf/Kcnj6tm1Stf
(involves: 129S1/Sv * 129X1/SvJ) 		environmentally induced seizures J:38206
increased susceptibility to pharmacologically induced seizures J:38206
Kcnk2tm1Lzd/Kcnk2tm1Lzd
(involves: 129 * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:91531
Kcnq2Nmf134/Kcnq2+
(C57BL/6J-Kcnq2Nmf134/J) 		abnormal seizure response to electrical stimulation J:82238
Kcnq2Nmf134/Kcnq2+
(C57BL/6J-Kcnq2Nmf134) 		abnormal seizure response to electrical stimulation J:136510
increased susceptibility to pharmacologically induced seizures J:136510
Kcnq2Nmf134/Kcnq2Nmf134
(C57BL/6J-Kcnq2Nmf134/J) 		abnormal seizure response to electrical stimulation J:82238
Kcnq2tm1.1Naas/Kcnq2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal seizure response to electrical stimulation J:154582
Kcnq2tm1Dgen/Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Kcnq2tm1Hsa/Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:62797
Kcnq3tm1.1Naas/Kcnq3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal seizure response to electrical stimulation J:154582
Kcnq3tm1.1Naas/Kcnq3+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		abnormal seizure response to electrical stimulation J:154582
Kcnt1em1Lekk/Kcnt1+
(C57BL/6J-Kcnt1em1Lekk) 		increased susceptibility to pharmacologically induced seizures J:287751
Kcnt1tm1.2Acsc/Kcnt1tm1.2Acsc
(involves: 129 * C57BL/6N) 		abnormal seizure response to electrical stimulation J:287751
Kdm1atm1Ebg/Kdm1atm1Ebg
(B6.129-Kdm1atm1Ebg) 		decreased susceptibility to pharmacologically induced seizures J:235553
Klk8tm1Lth/Klk8tm1Lth
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:71533
L2hgdhGt(DC0625)Wtsi/L2hgdhGt(DC0625)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:228407
Lamp5em1Lmit/Lamp5+
(C57BL/6-Lamp5em1Lmit) 		increased susceptibility to pharmacologically induced seizures J:345459
Lamp5em1Lmit/Lamp5em1Lmit
(C57BL/6-Lamp5em1Lmit) 		increased susceptibility to pharmacologically induced seizures J:345459
Letm1Gt(CC0204)Wtsi/Letm1+
(129S.129P2-Letm1Gt(CC0204)Wtsi) 		increased susceptibility to pharmacologically induced seizures J:222017
Letm1Gt(DD0926)Wtsi/Letm1+
(129S.129P2-Letm1Gt(DD0926)Wtsi) 		increased susceptibility to pharmacologically induced seizures J:222017
Lgi1tm1.1Ics/Lgi1+
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		audiogenic seizures J:182795
Lgi1tm1.1Ics/Lgi1tm1.1Ics
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		environmentally induced seizures J:182795
Lgi1tm1Mafu/Lgi1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:157578
Lhx6tm1Vpa/Lhx6tm2Vpa
(involves: 129P2/OlaHsd * C57BL/6) 		environmentally induced seizures J:198547
increased susceptibility to pharmacologically induced seizures J:198547
Lrrc4btm1Lex/Lrrc4btm1Lex
(involves: 129S/SvEv * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:276446
Mapk10tm1Flv/Mapk10tm1Flv
(involves: 129S1/Sv) 		decreased susceptibility to pharmacologically induced seizures J:43658
Mapttm1Hnd/Mapt+
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mapttm1Hnd/Mapt+
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mapttm1Hnd/Mapttm1Hnd
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mapttm1Hnd/Mapttm1Hnd
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased susceptibility to pharmacologically induced seizures J:121330
Mbnl2tm1.1Sws/Mbnl2+
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:218010
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:218010
Mbpjve/Mbpjve
(involves: C57BL/6J) 		environmentally induced seizures J:221049
Mbpshi/Mbpshi
(involves: C3H * ICR * SWV) 		audiogenic seizures J:6578
environmentally induced seizures J:6578
Mbpshi/Mbpshi
Tg(Thy1-YFP)HJrs/0
(involves: C3HeB/Fe * C57BL/6 * CBA * SWV) 		increased susceptibility to pharmacologically induced seizures J:158545
Mc2rtm1Dgen/Mc2rtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82809
Mecp2em1Jlzn/Y
(C57BL/6-Mecp2em1Jlzn) 		environmentally induced seizures J:296009
Mecp2tm3Meg/Y
(B6.129-Mecp2tm3Meg) 		increased susceptibility to pharmacologically induced seizures J:204723
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J) 		increased susceptibility to pharmacologically induced seizures J:89429
Mt3tm1Rpa/Mt3tm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:38222
n-TRtct5m1J/n-TRtct5m1J
(C57BL/6J) 		abnormal seizure response to electrical stimulation J:297745
abnormal seizure response to pharmacological agent J:297745
n-TRtct5tm1.1Slac/n-TRtct5tm1.1Slac
(C57BL/6J-n-TRtct5tm1.1Slac) 		abnormal seizure response to electrical stimulation J:297745
abnormal seizure response to pharmacological agent J:297745
n-TRtct5tm2.1Slac/n-TRtct5tm2.1Slac
(C57BL/6NJ-n-TRtct5tm2.1Slac) 		abnormal seizure response to pharmacological agent J:297745
Ndufs4tm1.1Rpa/Ndufs4tm1.1Rpa
(involves: 129S4/SvJaeSor) 		environmentally induced seizures J:161393
Ndufs4tm1Rpa/Ndufs4tm1Rpa
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL) 		environmentally induced seizures J:161393
Neurod2tm1Tap/Neurod2tm1Tap
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:69606
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		increased susceptibility to pharmacologically induced seizures J:218959
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:210491
abnormal seizure response to pharmacological agent J:210491
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
Gys1tm1c(EUCOMM)Wtsi/Gys1+
Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:210491
abnormal seizure response to pharmacological agent J:210491
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
Gys1tm1c(EUCOMM)Wtsi/Gys1tm1c(EUCOMM)Wtsi
Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac) 		abnormal seizure response to electrical stimulation J:210491
abnormal seizure response to pharmacological agent J:210491
Nmf31/Nmf31+
(BALB/cByJ-Nmf31/J) 		minimal clonic seizures J:78134
nmf88/nmf88
(C57BL/6J-nmf88/J) 		abnormal seizure response to electrical stimulation J:82238
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh) 		abnormal seizure response to inducing agent J:107964
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau) 		increased susceptibility to pharmacologically induced seizures J:107300
Nos3tm1Plh/Nos3tm1Plh
(B6.129S4-Nos3tm1Plh) 		abnormal seizure response to inducing agent J:107964
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:124729
Npytm1Rpa/Npytm1Rpa
(involves: 129S7/SvEvBrd) 		increased susceptibility to pharmacologically induced seizures J:33261
Npytm2Rpa/Npytm2Rpa
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:104699
Nr4a3tm1Omc/Nr4a3tm1Omc
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:93320
Nrp2tm1.2Mom/Nrp2+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ) 		environmentally induced seizures J:166116
increased susceptibility to pharmacologically induced seizures J:166116
Nrp2tm1.2Mom/Nrp2tm1.2Mom
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ) 		environmentally induced seizures J:166116
increased susceptibility to pharmacologically induced seizures J:166116
Ntrk2tm1Jom/Ntrk2+
Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR) 		decreased kindling response J:91467
Ntrk2tm1Jom/Ntrk2tm1Jom
Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR) 		decreased kindling response J:91467
Oprd1tm1Dgen/Oprd1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
P2rx6tm1Dgen/P2rx6tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:82809
Pahm1Btlr/Pahm1Btlr
(C57BL/6J-Pahm1Btlr) 		audiogenic seizures J:152890
environmentally induced seizures J:152890
Panx1tm1.1Fama/Panx1tm1.1Fama
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:177671
Panx1tm1a(KOMP)Wtsi/Panx1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased susceptibility to pharmacologically induced seizures J:177671
Pcmt1tm1Scl/Pcmt1tm1Scl
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:40967
Pde8atm1Dgen/Pde8atm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82809
Pdyntm1(cre)Czer/Pdyn+
(B6.Cg-Pdyntm1(cre)Czer) 		increased susceptibility to pharmacologically induced seizures J:122651
Pdyntm1(cre)Czer/Pdyntm1(cre)Czer
(B6.Cg-Pdyntm1(cre)Czer) 		increased susceptibility to pharmacologically induced seizures J:122651
Phf6em1Azbi/Y
(B6.Cg-Phf6em1Azbi) 		increased susceptibility to pharmacologically induced seizures J:271089
Pis1A/J/Pis1A/J
(C57BL/6J-Chr 10A/J/NaJ) 		increased susceptibility to pharmacologically induced seizures J:118211
Pis2A/J/Pis2A/J
(C57BL/6J-Chr 18A/J/NaJ) 		increased susceptibility to pharmacologically induced seizures J:118211
Plaurtm1Mlg/Plaurtm1Mlg
(B6.Cg-Plaurtm1Mlg) 		increased susceptibility to pharmacologically induced seizures J:81735
Plcb1tm1Hssh/Plcb1tm1Hssh
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:43077
Plcl1tm1Mh/Plcl1tm1Mh
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:92956
Plp1jp/Y
(Not Specified) 		environmentally induced seizures J:288
Plppr5em2Gpt/Plppr5em2Gpt
(C57BL/6-Plppr5em2Gpt) 		increased susceptibility to pharmacologically induced seizures J:324004
Ppp1r9btm1Jfe/Ppp1r9btm1Jfe
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:77284
Prickle1em1Yzou/Prickle1+
(C57BL/6-Prickle1em1Yzou) 		increased susceptibility to pharmacologically induced seizures J:321396
Prickle1m1Ingm/Prickle1+
(involves: C57BL/6) 		abnormal seizure response to electrical stimulation J:169136
Prickle1m2Ingm/Prickle1+
(C57BL/6-Prickle1m2Ingm) 		abnormal seizure response to electrical stimulation J:169136
Prickle1tm1Nue/Prickle1+
(B6.Cg-Prickle1tm1Nue) 		abnormal seizure response to electrical stimulation J:169136
Prickle2tm1Nue/Prickle2+
(B6.Cg-Prickle2tm1Nue) 		abnormal seizure response to electrical stimulation J:169136
Prickle2tm1Nue/Prickle2tm1Nue
(B6.Cg-Prickle2tm1Nue) 		abnormal seizure response to electrical stimulation J:169136
increased susceptibility to pharmacologically induced seizures J:169136
Prrt2tm1a(KOMP)Wtsi/Prrt2tm1a(KOMP)Wtsi
(C57BL/6N-Atm1Brd Prrt2tm1a(KOMP)Wtsi/Wtsi) 		audiogenic seizures J:237823
increased susceptibility to pharmacologically induced seizures J:237823
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac) 		increased susceptibility to pharmacologically induced seizures J:141610
Ptprotm1Dgen/Ptprotm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Rbfox1tm1.1Dblk/Rbfox1+
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:176189
Rbfox1tm1.1Dblk/Rbfox1tm1.1Dblk
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL) 		increased susceptibility to pharmacologically induced seizures J:176189
Rbfox3tm1a(EUCOMM)Hmgu/Rbfox3tm1a(EUCOMM)Hmgu
(B6Dnk;B6N-Rbfox3tm1a(EUCOMM)Hmgu/H) 		increased susceptibility to pharmacologically induced seizures J:234043
Rogditm1.2Ics/Rogditm1.2Ics
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:344072
Ryr2tm1Slh/Ryr2+
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:235432
Ryr2tm2Amks/Ryr2+
(B6.129-Ryr2tm2Amks) 		increased susceptibility to pharmacologically induced seizures J:137696
Ryr2tm2Amks/Ryr2tm2Amks
(B6.129-Ryr2tm2Amks) 		increased susceptibility to pharmacologically induced seizures J:137696
Scamp5tm1Smoc/Scamp5tm1Smoc
(involves: C57BL/6J) 		audiogenic seizures J:288324
Scn1aem1Anord/Scn1a+
(C57BL/6N-Scn1aem1Anord) 		environmentally induced seizures J:333350
increased susceptibility to pharmacologically induced seizures J:333350
Scn1aem1Anord/Scn1aem1Anord
(C57BL/6N-Scn1aem1Anord) 		environmentally induced seizures J:333350
Scn1atm1.1Aesc/Scn1a+
(involves: 129X1/SvJ * C57BL/6J * SJL) 		environmentally induced seizures J:161191
increased susceptibility to pharmacologically induced seizures J:161191
Scn1atm1.1Aesc/Scn1a+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:170734
Scn1atm1.1Aesc/Scn1atm1.1Aesc
(involves: 129X1/SvJ * C57BL/6J * SJL) 		environmentally induced seizures J:161191
maximal tonic hindlimb extension seizures J:161191
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:209093
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C3HeB/FeJ) 		environmentally induced seizures J:260796
Scn1atm1.1Swl/Scn1a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl) 		environmentally induced seizures J:221045
Scn1atm1Wac/Scn1a+
(involves: 129S1/Sv * 129X1/SvJ * FVB/NJ) 		increased susceptibility to pharmacologically induced seizures J:129998
Scn1atm2.1Wac/Scn1a+
Tg(I12b-cre)1Jlr/0
(involves: C57BL/6J * CD-1) 		environmentally induced seizures J:189897
Scn1btm1.1Bion/Scn1b+
(Not Specified) 		environmentally induced seizures J:163771
Scn1btm1.1Bion/Scn1btm1.1Bion
(Not Specified) 		environmentally induced seizures J:163771
Scn2btm1Isom/Scn2btm1Isom
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:82050
Scn8amed-jo/Scn8a+
(B6.D2-Scn8amed-jo/J) 		decreased susceptibility to pharmacologically induced seizures J:170734, J:129998
Scn8amed/Scn8a+
(C3Fe.Cg-Scn8amed/J) 		decreased susceptibility to pharmacologically induced seizures J:129998
Scn9atm1.1Naas/Scn9atm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal seizure response to electrical stimulation J:154118
minimal clonic seizures J:154118
Scn9atm1.1Naas/Scn9atm1.1Naas
(B6.129-Scn9atm1.1Naas) 		abnormal kindling response J:154118
Senp2tm1Eyeh/Senp2tm1Eyeh
(Not Specified) 		audiogenic seizures J:217910
Serpine2tm1Dmn/Serpine2tm1Dmn
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:40953
Sez6tm1.1Sest/Sez6tm1.1Sest
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to pharmacologically induced seizures J:132725
Shank3tm1.1Cya/Shank3tm1.1Cya
(B6.Cg-Shank3tm1.1Cya) 		decreased susceptibility to pharmacologically induced seizures J:281328
Shank3tm2Gfng/Shank3tm2Gfng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:171113
Sicd1C57BL/6J/Sicd1C57BL/6J
(FVB.B6-(D18Mit141-D18Mit25)) 		increased susceptibility to pharmacologically induced seizures J:122922
sims/sims
(B6.Cg-sims/GrsrJ) 		audiogenic seizures J:161505
sims/sims+
(B6.Cg-sims/GrsrJ) 		environmentally induced seizures J:161505
Sipa1l1tm1Taki/Sipa1l1tm1Taki
(B6.Cg-Sipa1l1tm1Taki/Taki) 		increased susceptibility to pharmacologically induced seizures J:345320
Slc1a2tm1Kta/Slc1a2tm1Kta
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:40984
Slc1a3tm1Kta/Slc1a3tm1Kta
(involves: 129P2/OlaHsd) 		abnormal kindling response J:58180
increased susceptibility to pharmacologically induced seizures J:58180
Slc4a3tm1Cahb/Slc4a3tm1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:104157
Slc4a10tm1.1Cahb/Slc4a10tm1.1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:131058
Slc6a11tm1Dgen/Slc6a11+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
Slc7a8tm1Dgen/Slc7a8tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to pharmacologically induced seizures J:101679
Slc9a6tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:101679
Slc10a4tm1Tigm/Slc10a4tm1Tigm
(involves: 129S/SvEvBrd) 		increased susceptibility to pharmacologically induced seizures J:196996
Slc12a5tm1Dlp/Slc12a5+
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:113307
Slc12a5tm1Hsav/Slc12a5tm2Hsav
(involves: 129S1/Sv * 129S2/SvPasHsd * 129X1/SvJ * C57BL/6J * C57BL/6JOlaHsd) 		increased susceptibility to pharmacologically induced seizures J:101079
Slc12a6tm1Tjj/Slc12a6tm1Tjj
(involves: 129/Sv * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:86183
Slc17a5tm1Lex/Slc17a5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		environmentally induced seizures J:158444
Slc18a3tm1Mca/Slc18a3tm1Mca
(involves: 129S4/SvJae * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:136620
Slc32a1tm2(cre)Lowl/Slc32a1tm2(cre)Lowl
(either: B6J.129S6(FVB)-Slc32a1tm2(cre)Lowl or (involves: 129S6/SvEvTac * C57BL/6J * FVB/N)) 		increased kindling response J:308516
Slitrk3tm1Jaru/Slitrk3tm1Jaru
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:232385
St3gal4tm1.1Bsi/St3gal4tm1.1Bsi
(B6J.B6N-St3gal4tm1.1Bsi) 		decreased kindling response J:217104
Stamtm1Sug/Stamtm1Sug
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to pharmacologically induced seizures J:69504
Syn1tm1Pggd/Syn1tm1Pggd
(involves: 129) 		abnormal seizure response to electrical stimulation J:29086
Syn1tm1Pggd/Syn1tm1Pggd
Syn2tm1Pggd/Syn2tm1Pggd
Syn3tm1Pggd/Syn3tm1Pggd
(involves: 129 * 129P2/OlaHsd * 129X1/SvJ * C57BL/6) 		environmentally induced seizures J:175256
Syngap1tm1Rlh/Syngap1+
(involves: 129S1/Sv * 129X1/SvJ) 		audiogenic seizures J:193208
increased susceptibility to pharmacologically induced seizures J:193208
Szs1C57BL/6J/Szs1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
Szs1DBA/2J/Szs1DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
Szs1DBA/2J/Szs1DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs1DBA/2J/Szs1DBA/2J
(involves: B6.D2-Mtv7a/Ty * C57BL/6J) 		abnormal seizure response to electrical stimulation J:89732
Szs2C57BL/6J/Szs2C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:38888
Szs2C57BL/6J/Szs2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:38888
Szs5DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
Szs6C57BL/6J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:56630
Szs7DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs8DBA/2J/Szs8C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs8DBA/2J/Szs8DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs9C57BL/6J/Szs9DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs9DBA/2J/Szs9DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to electrical stimulation J:70295
Szs10C57BL/6J/Szs10C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs10C57BL/6J/Szs10DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs11C57BL/6J/Szs11C57BL/6J
(D2.B6-(D5Mit345-D5Mit403)) 		abnormal seizure response to electrical stimulation J:129499
Szs11DBA/2J/Szs11C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs11DBA/2J/Szs11DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs11DBA/2J/Szs11DBA/2J
(B6.D2-(D5Mit75-D5Mit403)) 		abnormal seizure response to electrical stimulation J:129499
Szs12DBA/2J/Szs12C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs12DBA/2J/Szs12DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs13DBA/2J/Szs13C57BL/6J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szs13DBA/2J/Szs13DBA/2J
(involves: B6.D2-Mtv7a/Ty) 		abnormal seizure response to electrical stimulation J:70295
Szt1/Szt1+
(involves: BALB/cByJ * BALB/cJ * C57BL/6J) 		abnormal seizure response to electrical stimulation J:82964
abnormal seizure response to pharmacological agent J:82964
Szt1/Szt1+
(C57BL/6J-Szt1) 		abnormal seizure response to electrical stimulation J:136510
Szt2Gt(XH662)Byg/Szt2+
(involves: 129P2/OlaHsd * C57BL/6J) 		minimal clonic seizures J:150942
Szt2Gt(XH662)Byg/Szt2Gt(XH662)Byg
(129S1.129P2(B6)-Szt2Gt(XH662)Byg/FrkJ) 		maximal tonic hindlimb extension seizures J:150942
minimal clonic seizures J:150942
Szt2Gt(XH662)Byg/Szt2m1Frk
(involves: 129P2/OlaHsd * C57BL/6J) 		minimal clonic seizures J:150942
Szt2m1Frk/Szt2m1Frk
(C57BL/6J-Szt2m1Frk) 		abnormal kindling response J:150942
minimal clonic seizures J:150942
Szt2m1Frk/Szt2m1Frk
(involves: BALB/cByJ * C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:150942
minimal clonic seizures J:150942
Szv1C57BL/6J/Szv1C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
Szv2C57BL/6J/Szv2C57BL/6J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
Szv2C57BL/6J/Szv2DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:38888
Szv3C57BL/6J/Szv3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:70295
Szv3DBA/2J/Szv3DBA/2J
(involves: C57BL/6J * DBA/2J) 		abnormal seizure response to pharmacological agent J:70295
Tectatm3.1Gpr/Tecta+
(involves: 129S/SvEv) 		audiogenic seizures J:203482
Tectatm4.1Gpr/Tecta+
(involves: 129S/SvEv) 		audiogenic seizures J:203482
Tectatm5.1Gpr/Tecta+
(involves: 129S/SvEv) 		audiogenic seizures J:203482
Tg(CAG-cre/Esr1*)5Amc/0
Ube3atm1Yelg/Ube3a+
(involves: 129P2/OlaHsd * 129S2/SvPasCrl * C57BL/6J) 		audiogenic seizures J:222400
Tg(Camk2a-Bdnf)A9Stl/0
(C57BL/6-Tg(Camk2a-Bdnf)A9Stl/J) 		psychomotor seizures J:216846
Tg(Camk2a-Crem)I15Endo/0
(involves: C3H * C57BL/6) 		abnormal kindling response J:137666
Tg(Camk2a-Crem)IIEndo/0
(C57BL/6-Tg(Camk2a-Crem)IIEndo/EndoRbrc) 		abnormal kindling response J:137666
Tg(Camk2a-Fyn-531)1Nko/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		abnormal kindling response J:59490
abnormal seizure response to electrical stimulation J:59490
increased susceptibility to pharmacologically induced seizures J:59490
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-MAPT)32Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT)32Lms) 		increased susceptibility to pharmacologically induced seizures J:233816
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-MAPT*A152T)L1Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT*A152T)L1Lms) 		increased susceptibility to pharmacologically induced seizures J:233816
Tg(DBH-Gal)1923Stei/0
(B6.Cg-Tg(DBH-Gal)1923Stei) 		decreased susceptibility to pharmacologically induced seizures J:77625
Tg(GFAP-EFNA3)181Kln/0
(involves: C57BL/6 * FVB) 		increased susceptibility to pharmacologically induced seizures J:154648
Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:139349
Tg(Lgi1*)#Mpan/0
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:154129
Tg(Lmnb1)1Yfu/0
(involves: C57BL/6J) 		increased susceptibility to pharmacologically induced seizures J:197168
Tg(Mov1/Tyr)OVE876BPay/Y
(FVB/N-Tg(Mov1/Tyr)OVE876BPay) 		audiogenic seizures J:167614
Tg(Mov1/Tyr)OVE876BPay/Tg(Mov1/Tyr)OVE876BPay
(FVB/N-Tg(Mov1/Tyr)OVE876BPay) 		audiogenic seizures J:167614
Tg(PLP1*)4Rsj/0
(involves: CD-1) 		environmentally induced seizures J:24069
Tg(Plp1-HTT*150Q)4aXjl/0
(Not Specified) 		increased susceptibility to pharmacologically induced seizures J:221608
Tg(Prnp-lacZ/ATXN10*)#Teas/0
(involves: FVB/N) 		increased susceptibility to pharmacologically induced seizures J:222081
Tg(Prnp-tTA)F959Sbp/?
Tg(TetO-Nfkbia*S32A*S36A)1Wcg/?
(involves: 129S7/SvEvBrd * DBA * FVB/N) 		environmentally induced seizures J:112973
Tg(Scn1a*)RH9Aesc/0
(involves: FVB/NJ) 		increased susceptibility to pharmacologically induced seizures J:150454
Tg(Thy1-App*R609D*K612E)4Vln/Tg(Thy1-App*R609D*K612E)4Vln
(involves: FVB) 		decreased susceptibility to pharmacologically induced seizures J:32213
increased susceptibility to pharmacologically induced seizures J:32213
Tg(Thy1-App*R609D*K612E)6Vln/Tg(Thy1-App*R609D*K612E)6Vln
(involves: FVB) 		decreased susceptibility to pharmacologically induced seizures J:32213
increased susceptibility to pharmacologically induced seizures J:32213
Tg(Thy1-MAPT*)1Avil/Tg(Thy1-MAPT*)1Avil
(involves: C57BL/6 * CBA) 		increased susceptibility to pharmacologically induced seizures J:201700
Tg(Thy1-SERPINI1*G392E)333Icka/0
(involves: C57BL * CD-1 * DBA) 		increased susceptibility to pharmacologically induced seizures J:144649
Tg(Thy1-SERPINI1*G392E)333Icka/Tg(Thy1-SERPINI1*G392E)333Icka
(involves: C57BL * CD-1 * DBA) 		increased susceptibility to pharmacologically induced seizures J:144649
Tg(UBC-Adk)1Bois/0
(B6;129P3-Adktm1Bois Tg(UBC-Adk)1Bois) 		abnormal seizure response to pharmacological agent J:105483
Thrbtm1Df/Thrbtm1Df
(either: B6.129S1-Thrbtm1Df or (involves: 129S1/Sv * C57BL/6J)) 		audiogenic seizures J:103702
tmgc61/tmgc61
(Mixed stock) 		decreased susceptibility to pharmacologically induced seizures J:92490
Tpp1tm1Plob/Tpp1tm1Plob
(involves: 129S1/Sv * C57BL/6) 		audiogenic seizures J:94884
Trim3tm1Mak/Trim3tm1Mak
(B6.129P2-Trim3tm1Mak) 		decreased susceptibility to pharmacologically induced seizures J:161372
Trpc5tm1.1Lbi/Y
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:194590
Trpc5tm1.1Lbi/Trpc5tm1.1Lbi
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		decreased susceptibility to pharmacologically induced seizures J:194590
Tsc2tm1.1Kcess/Tsc2tm1.1Kcess
Emx1tm1(cre)Krj/Emx1+
(involves: 129S/Sv * C57BL/6J) 		environmentally induced seizures J:195049
Tubg1tm1.1Ics/Tubg1+
(involves: C57BL/6N) 		increased susceptibility to pharmacologically induced seizures J:275532
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal seizure response to inducing agent J:54681
Ube3atm1Alb/Ube3a+
(involves: 129S7/SvEvBrd * C57BL/6) 		audiogenic seizures J:50811
Ube3atm1Alb/Ube3a+
(involves: 129S7/SvEvBrd) 		audiogenic seizures J:50811
Ube3atm1Alb/Ube3atm1Alb
(involves: 129S7/SvEvBrd * C57BL/6) 		audiogenic seizures J:50811
Ube3atm1Alb/Ube3atm1Alb
(involves: 129S7/SvEvBrd) 		audiogenic seizures J:50811
Ube3atm1Yelg/Ube3a+
(involves: 129P2/OlaHsd * 129S2/SvPasCrl) 		audiogenic seizures J:222400
Usf1tm1Msw/Usf1tm1Msw
(involves: 129S7/SvEvBrd * C57BL/6) 		environmentally induced seizures J:46788
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: C57BL/6 * DBA/2) 		increased susceptibility to pharmacologically induced seizures J:121330
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/30/2024
MGI 6.23 		The Jackson Laboratory